FMR LLC 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-10 10:03 am Sale | 2024-05-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FMR LLC | 522,877 0.287% | -9,168,974 (-94.60%) | Filing |
| 2024-01-10 08:53 am Sale | 2024-01-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FMR LLC | 9,691,851 5.365% | -13,761,937 (-58.68%) | Filing |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FMR LLC | 23,453,788 14.999% | 3,943,975 (+20.22%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FMR LLC | 19,509,813 13.250% | 2,935,922 (+17.71%) | Filing |
| 2021-08-10 10:33 am Purchase | 2021-08-09 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FMR LLC | 16,573,891 11.727% | 16,573,891 (New Position) | Filing |